intermediate salinities. Growth rates of A. aegypti decrease with increasing salinity, and percent body water is constant across salinities. As for O. taeniorhynchus, duration of A. aegypti larval stage increases at high salinity. However, this increase in larval stage duration cannot compensate for the decrease in growth rate at high salinity, resulting in an overall decrease in both wet and dry pupal mass at high salinity. Thus, salinity has fundamentally different effects on developmental programs and phenotypic plasticity in the two species investigated.
The pH regulatory abilities of two members of the mosquito tribe Aedini, known to have dramatically different saline tolerances, are investigated. The freshwater mosquito Aedes aegypti and the euryhaline Ochlerotatus taeniorhynchus tolerate very similar pH ranges. Both species complete larval development in waters ranging from pH·4 to pH·11, but naïve larvae always die in water of pH·3 or 12. Across the pH range 4-11, the hemolymph pH of O. taeniorhynchus is maintained constant while that of A. aegypti varies by 0.1 pH units. The salt composition of the water (3.5·g·l -1 sea salt, 3.5·g·l -1 NaCl, or nominally salt-free) has no effect on the range of pH tolerated by A. aegypti. In both species, the effects of pH on larval growth and development are minor in comparison with the influence of species and sex. Acclimation of A. aegypti to pH·4 or 11 increases survival times in pH·3 or 12, respectively, and allows a small percentage of larvae to pupate successfully at these extreme pH values. Such acclimation does not compromise survival at the other pH extreme.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.